Effects of Walking and Heating on Vascular Function in Diabetic Patients

NCT ID: NCT03203694

Last Updated: 2024-04-04

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

99 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-12-04

Study Completion Date

2022-03-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the present study is to determine the effects of increased walking and lower body heating on leg vascular function in patients with type 2 diabetes (T2D).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The notion that habitual aerobic exercise increases insulin-induced vasodilation is largely founded on rodent studies, hence the urgent need for human studies, especially in patients with type 2 diabetes (T2D). For example, it remains unknown if increased walking, the most common form of physical activity, enhances skeletal muscle vasodilator actions of insulin in T2D. In addition, the molecular mechanisms by which exercise improves vasoreactivity to insulin have not been examined in humans. The investigators propose that in T2D patients who are sedentary (i.e., the vast majority), increased leg blood flow with walking or local heating signifies a vital strategy to correct vascular insulin resistance. This study will establish whether increased physical activity and associated hemodynamic forces (e.g., shear stress) are a direct form of vascular medicine in humans.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 2 Diabetes Mellitus Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Participants will be assigned to either a walking, a lower body heating, or no intervention.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Walking: Intervention arm in diabetics

The walking program will consist of 45 minutes of walking (at a moderate pace) 5 days per week for 8 weeks.

Group Type EXPERIMENTAL

Walking: Intervention arm in diabetics

Intervention Type BEHAVIORAL

The walking program will consist of 45 minutes of walking (at a moderate pace) 5 days per week for 8 weeks.

Walking: No intervention in diabetics

Subjects will be instructed to continue their usual lifestyle for 8 weeks.

Group Type EXPERIMENTAL

Walking: No intervention in diabetics

Intervention Type OTHER

Subjects will be instructed to continue their usual lifestyle for 8 weeks.

Walking: Healthy cohort as reference controls

Subjects will be studied at one time only.

Group Type OTHER

Walking: Healthy cohort as reference controls

Intervention Type OTHER

Subjects will be studied at one time only.

Lower body heating: Intervention arm in healthy subjects

This intervention consists of 60 minutes of lower body heating (40-42 degree C).

Group Type EXPERIMENTAL

Lower body heating: Intervention arm in healthy subjects

Intervention Type BEHAVIORAL

This intervention consists of 60 minutes of lower body heating (40-42 degree C).

Lower body heating: Intervention arm in diabetics

This intervention consists of 60 minutes of lower body heating (40-42 degree C) 7 days per week for 7 days.

Group Type EXPERIMENTAL

Lower body heating: Intervention arm in diabetics

Intervention Type BEHAVIORAL

This intervention consists of 60 minutes of lower body heating (40-42 degree C) 7 days per week for 7 days.

Lower body heating: Healthy cohort as reference controls

Subjects will be studied at one time only.

Group Type OTHER

Lower body heating: Healthy cohort as reference controls

Intervention Type OTHER

Subjects will be studied at one time only.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Walking: Intervention arm in diabetics

The walking program will consist of 45 minutes of walking (at a moderate pace) 5 days per week for 8 weeks.

Intervention Type BEHAVIORAL

Walking: No intervention in diabetics

Subjects will be instructed to continue their usual lifestyle for 8 weeks.

Intervention Type OTHER

Walking: Healthy cohort as reference controls

Subjects will be studied at one time only.

Intervention Type OTHER

Lower body heating: Intervention arm in healthy subjects

This intervention consists of 60 minutes of lower body heating (40-42 degree C).

Intervention Type BEHAVIORAL

Lower body heating: Intervention arm in diabetics

This intervention consists of 60 minutes of lower body heating (40-42 degree C) 7 days per week for 7 days.

Intervention Type BEHAVIORAL

Lower body heating: Healthy cohort as reference controls

Subjects will be studied at one time only.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients with type 2 diabetes who are overweight and obese (BMI 25-50 kg/m2), 35 to 65 years of age, and sedentary (\<60 minutes structured exercise/week). Healthy volunteers without type 2 diabetes: 18 to 65 years of age.

Exclusion Criteria

1. Cardiovascular disease including myocardial infraction, heart failure, coronary artery disease, stroke;
2. renal or hepatic diseases;
3. active cancer;
4. autoimmune diseases;
5. immunosuppressant therapy;
6. excessive alcohol consumption (\>14 drinks/week for men; \>7 drinks/week for women);
7. current tobacco use;
8. pregnancy;
9. mobility limitations;
10. foot ulcers;
11. diabetic neuropathy
12. uncontrolled hypertension (\>=180 systolic / 100 diastolic mmHg)
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Missouri-Columbia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jaume Padilla

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jaume Padilla, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Missouri-Columbia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Missouri

Columbia, Missouri, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Document Type: Informed Consent Form: Lower body heating

View Document

Document Type: Informed Consent Form: Lower body heating: Healthy cohort as reference controls

View Document

Document Type: Informed Consent Form: Walking

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2008181

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Self-Managed Walking Improves Function
NCT00611988 COMPLETED PHASE2